After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
OPPO Reno 9 Series Leaked Specification: Oppo has been in discussion about the launch of its new
On the lines of JEE and NEET to be conducted for admission in engineering and medical education i
In the case of the death of three students in the basement of Rau Coaching Center, it has been re
Covid Vaccination: The corona vaccination campaign is going on fast in the country. Meanwhile, to
Apple: Every fourth iPhone may be made in India by 2025, Apple wants to stop its production in China
Apple may make every fourth iPhone in India by 2025. Analysts at JPMorgan said on Wednesday that
Yashasvi Jaiswal is in a lot of discussions these days. He is in the dock after Team India's defe
The Indian team created history by defeating South Africa in Cape Town. With this victory, he dre
Ravindra Jadeja celebrates in Pushpa style after taking the wicket of Dinesh Chandimal in the fir
The Australian women's team created history on Sunday by chasing a target of 331 runs against Ind
A new decree has been issued in the Taliban for women who do not wear hijab. In Afghanistan's Bal
